Special clinical interest in myeloma, lymphoma, chronic lymphocytic leukaemia (CLL) and general haematology.
Dr Kothari is a Consultant Haematologist based in Oxford.
After obtaining a 1st class degree in Medical Sciences from Peterhouse, University of Cambridge, he completed his medical training at The University of Oxford. He subsequently worked in London, completing advanced haematology training at University College Hospital London, including an advanced fellowship focused on the comprehensive treatment of myeloma and related conditions. He currently specialises in the treatment of myeloma, lymphoma and associated disorders.
Dr Kothari is a co-chair of the Thames Valley regional myeloma multi-disciplinary team meeting.
He was appointed as an honorary Senior Lecturer in Haematology at The University of Oxford in October 2016. He is also a trustee of the charity WMUK and has a special interest in the management of this disorder. He also has wide experience in the full range of consultative haematology.
- Clinical Haematology
Dr Kothari is the Clinical Lead for late phase clinical trials for haematology at Oxford University Hospitals NHS Trust. In his trial capacity, he has a wide-reaching overview and understanding of clinical trials and the development of novel therapeutics and acts as a Principal Investigator (PI) for trials in myeloma and lymphoma.
NHS Hospital / current post(s)
- Consultant Haematologist, Oxford University Hospitals NHS Trust
- Honorary Senior Lecturer in Haematology, University of Oxford
- Member of The Royal College of Physicians (MRCP)
- Fellow of The Royal College of Pathologists (FRCPath)
- Member British Society of Haematology (BSH)
- Trustee of Waldenstrom’s Macroglobulinaemia-UK (WMUK)